Litigation Details for CyDex Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2019)

CyDex Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2019)

Docket		Date Filed	2019-10-29
Court	District Court, D. Delaware	Date Terminated	2021-05-03
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	CYDEX PHARMACEUTICALS, INC.
Patents	10,040,872; 8,410,077; 9,200,088; 9,493,582
Attorneys	Lance A. Soderstrom
Firms	Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Details for CyDex Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2019-12-10	11	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,077 ;10,040,872 . (Phillips, …October 2019 3 May 2021 1:19-cv-02043 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-04-26	38	Consent Judgment - Proposed	of United States Patent Nos. 9,200,088 and 9,493,582 (collectively, the “CyDex Patents”). CyDex’s commencement… States or with respect to any patent other than the CyDex Patents. 10. For purposes of…JUDGMENT AND DISMISSAL ORDER This action for patent infringement (the “Litigation”) has been brought…§ 355(j)(2)(A)(vii)(IV) directed to the CyDex Patents and seeking approval to market a generic melphalan…injection prior to the expiration of the CyDex Patents. CyDex and Lupin have agreed to enter into	External link to document
2019-10-29	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,200,088 B2 and 9,493,582 B2…October 2019 3 May 2021 1:19-cv-02043 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document